RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/BxfGTHDlo0
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYvSxWT Ref: https://t.co/myx7pxuzg9 #coronavirus #COVIDー19 #sarscov2 #foam #foamed #foamems #meded #foamcc #covid19primaria #mfyc #enarm #
@carpraba @julianig @alaska_doctor Si los hay. Aquí les dejo uno, claro que debe haber una buena valoración para ver si se es apto para la administración de anticoagulantes (en este caso heparina de bajo peso molecular). https://t.co/7ta1E7TbJX
@alaska_doctor Os he hecho una recopilación de Papers a este respecto (no de Italia) : Por si os ayuda https://t.co/xcicDumjhX https://t.co/NLMoLdgOpD https://t.co/mj71I89Gov https://t.co/GunyTWvskL https://t.co/VNNK8bXu4P https://t.co/AMe3w5VX0Q También r
@Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant therapy mainly with LMWH appears to be associated with better prognosis in severe COVID‐19 patients meeting SIC criteria or with markedly elevated D‐dimer. [Mar 27, 2020] Tang et al. @JTHjournal http
@Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [Mar 27, 2020] Tang et al. @JTHjournal https://t.co/yiuv1YYb5g #VTE #2019nCoV #COVID19
RT @alejandrosuazov: El coronavirus aparentemente no causa neumonía, sino trombosis de acuerdo a últimos estudios. Es la forma como se ha c…
RT @sanchak74: @DanielPhife @cryptodrew1 I would add some anticoagulation to the therapy... https://t.co/Nwvs7gTXAy https://t.co/uZ0CWVAARo
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @mtmdphd: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy […
RT @sanchak74: @lachlanjmc Everything adds up. Just reading this paper from Wuhan. https://t.co/JwnxbF3x1q With lesser D-dimers, deaths re…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @ToshiAkima: @andresorquera @Bloodman @isth @connors_md @JerroldLevy @JTHjournal I would start by reading this article in @JTHjournal as…
@andresorquera @Bloodman @isth @connors_md @JerroldLevy @JTHjournal I would start by reading this article in @JTHjournal as the review is almost an editorial commentary on it (I'm sure this article is open access already) https://t.co/zkmXeqqMf7
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
RT @NeilFlochMD: There is now evidence that mortality may be reduced significantly by the use of #heparin in critical intubated #ICU patien…
@OscarDev3 @Tommy45059349 @gstanchev @farid__jalali @lewistlc @aknappjr @monarchdiaries @dartsandmonkeys @DrSamGirgis Heparin also has anti-inflammatory properties. Anyway an antiplatelet drug like dipyridamole or a thrombin inhibitor like camostat/nafamo
@DrEricDing Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/GOwR8Qqqo6
@ethanjweiss https://t.co/TCVsCQkRIP In Itali heparin is being used. And soon the shortage of heparin will come to light too.
RT @JTHjournal: New accepted #COVID19 article shows #anticoagulant treatment is associated with decreased mortality in severe COVID-19 pati…
"Senza fondamento". https://t.co/V0aKjYU8pH https://t.co/FTgqoVrRtB
RT @Ricky_Turgeon: Yikes! Let's remind people that this is the only evidence re: anticoagulation (AC) in COVID-19: https://t.co/tj4ur5loh7…
RT @ErinSandersNP: 10/ Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Co…
@covidperspectiv Heparin has both anticoagulant and anti-inflammatory effects: https://t.co/DOg9BVj4w2
El coronavirus aparentemente no causa neumonía, sino trombosis de acuerdo a últimos estudios. Es la forma como se ha cambiado el protocolo en España. Y al parecer en Perú también. https://t.co/sE6Gl4Phn0
El tratamiento anticoagulante se asocia con una disminución de la mortalidad en pacientes con enfermedad grave por coronavirus 2019 con coagulopatía https://t.co/cGk9k3Yl43
More studies coming out from China regarding the role of anticoagulation in severe COVID19 patients with coagulopathy. No difference in overall mortality but maybe some benefit for the sicker patients (SIC score>4 or D-dimer>3). https://t.co/lXBQjV
@RobertoBurioni @NEJM @TheLancet sei un pagliaccio e pure un criminale se dici questo fai disinformazione vergognati non hai rispetto per i tuoi colleghi e le pubblicazione scientifiche dicono il contrario le informazioni prendile da Pubmed se sei un medic
RT @ReyPathology: El Covid19 está asociado a estados trombóticos https://t.co/MFKffWgAT6
RT @PamelaJohnsonMD: 4/ "The D‐dimer, prothrombin time and age were positively, and platelet count was negatively, correlated with 28‐day m…
@rlopezaliaga1 Es una condición asociada en algunos casos al COVID-19. Podría funcionar para ellos: https://t.co/szHwkuI3rM
RT @wbastos23: “the application of #heparin in COVID‐19 has been recommended by some expert consensus due to the risk of disseminated intra…
RT @wbastos23: “the application of #heparin in COVID‐19 has been recommended by some expert consensus due to the risk of disseminated intra…
Un nuevo giro en el tratamiento en pacientes covid-19, una nueva esperanza. https://t.co/RUdQllrsSr
ヘパリンやワーファリンがいいなら、セラペプチターゼもいいはずなんだけどな 痰も分解するんだけどな なんで、日本は売らなくなったんだろうな 新型コロナには良いお薬のはずなんだけどな 生き残りは痔のブロメラインだけなのか… https://t.co/nxmGNVvG7e
RT @chaumix: @DrGomi @olivierveran Cf les recos GIHP et GFHT. Citees dans la FAQ n•17 de @fredericadnet. c'est pas strictement pour la méde…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @Ricky_Turgeon: Yikes! Let's remind people that this is the only evidence re: anticoagulation (AC) in COVID-19: https://t.co/tj4ur5loh7…
RT @ATRIUMRx: Is anyone else bothered by how misleading the title & bullet points are to this study? #CardioTwitter #COVID19 @isth "Antic…
RT @ATRIUMRx: Is anyone else bothered by how misleading the title & bullet points are to this study? #CardioTwitter #COVID19 @isth "Antic…
Is anyone else bothered by how misleading the title & bullet points are to this study? #CardioTwitter #COVID19 @isth "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy" 1/n ht
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @chaumix: @DrGomi @olivierveran Cf les recos GIHP et GFHT. Citees dans la FAQ n•17 de @fredericadnet. c'est pas strictement pour la méde…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @chaumix: @DrGomi @olivierveran Cf les recos GIHP et GFHT. Citees dans la FAQ n•17 de @fredericadnet. c'est pas strictement pour la méde…
RT @chaumix: @DrGomi @olivierveran Cf les recos GIHP et GFHT. Citees dans la FAQ n•17 de @fredericadnet. c'est pas strictement pour la méde…
RT @anita15618428: @Nonha_stata https://t.co/EWaJd5lDGh è associata ad un miglioramento. L’efficacia mi pare troppo ottimista...ad ogni mo…
Sull'uso di #eparina nel #Covid_19 : "Anticoagulant treatment is associated with decreased mortality in severe #coronavirus disease 2019 patients with coagulopathy." #COVID19italia #coronavirusitalIa https://t.co/BTpwKkuhIB
RT @Ricky_Turgeon: Yikes! Let's remind people that this is the only evidence re: anticoagulation (AC) in COVID-19: https://t.co/tj4ur5loh7…
RT @anita15618428: @Nonha_stata https://t.co/EWaJd5lDGh è associata ad un miglioramento. L’efficacia mi pare troppo ottimista...ad ogni mo…
@Nonha_stata https://t.co/EWaJd5lDGh è associata ad un miglioramento. L’efficacia mi pare troppo ottimista...ad ogni modo questo è lo studio con i risultati ❤️di certo non é una bufala
@DrGomi @olivierveran Cf les recos GIHP et GFHT. Citees dans la FAQ n•17 de @fredericadnet. c'est pas strictement pour la médecine ambulatoire mais ça aide. Et cette etude aussi https://t.co/FplYvkUkTr
Great points! Follow @Ricky_Turgeon if you want great insights into trials and pharmacology.
RT @khalid_eljaaly2: Based on this study, would you recommend anticoagulants during #COVID19 therapy? How? https://t.co/Fl8dxesuR3
RT @Mareq16: Decreased mortality with anticoagulants: https://t.co/gvxCFMc0x9
RT @BrianGilberti: - These patients are hypercoaguable. We have seen PEs, DVTs, portal vein thrombosis, cereberal vein thrombosis, strokes.…
RT @Ricky_Turgeon: Yikes! Let's remind people that this is the only evidence re: anticoagulation (AC) in COVID-19: https://t.co/tj4ur5loh7…
RT @BrianGilberti: - These patients are hypercoaguable. We have seen PEs, DVTs, portal vein thrombosis, cereberal vein thrombosis, strokes.…
@KiraNewmanMDPhD I wonder if heparin is being used in current treatments of patients in Seattle. https://t.co/TCVsCQkRIP
Yikes! Let's remind people that this is the only evidence re: anticoagulation (AC) in COVID-19: https://t.co/tj4ur5loh7 A cohort study of n=449 tainted by immortal time bias. To be in AC group, had to get AC >7 days; if died after 6 days of AC = counted
@SaadTheodore @abtahi_parvaneh @VijayanMD @wasse_m @NephRodby @mrssaradavid @ASDINNews @dialysisaccess1 @criticalbeansmd People suggesting the LMWH superiority theory, can you provide a reference? The only paper I came across is this one—https://t.co/xxYAb